Independent Health has waived copayments or cost-sharing for COVID-19 medical testing, diagnosis and treatment at least through May 31, 2020. This applies to all fully insured commercial plans (including HSA-qualified high deductible health plans), Medicare Advantage, State Products and Individual plan members.
This coverage includes in-person visits and telehealth visits, urgent care center, outpatient hospital or emergency room visits when the primary purpose of the visit is COVID-19 testing, diagnosis and treatment.
Coverage for self-funded employer plans varies by employer group.
Telehealth and Telemedicine
To encourage social distancing and help reduce the risk of spreading this virus, Independent Health will cover any in-network telehealth/telemedicine services, whether or not COVID-19 related. There will be $0 copay or cost-sharing for members for these services. We’ve organized important information in the Telehealth Fee Schedule, Coverage Grid, and Policy.
Medicare Members are responsible for the cost share associated with ancillary services (e.g. dietitians).
Self-Funded Members should contact customer service at 716.631.2661 or 1.800.257.2753 for more information on telehealth benefits and the cost.
Although Independent Health encourages its members to contact their primary care physician for their medical needs, we realize this isn’t always possible. So, when a member can’t reach your primary care practice, Independent Health’s telemedicine benefit is provided through Teladoc®. Independent Health is waiving the cost share for Teladoc services during the COVID-19 outbreak.
Teladoc is not available to Essential Plan members and availability to self-funded members varies by employer group.
Coding for Services Related to COVID-19
Please follow ICD-10 CM Diagnosis Coding guidelines published by CDC if the need arises to report claims for COVID-19 related services. For claims with dates of service on or after April 1, 2020, there is a new diagnosis code for COVID-19 infection. The updated CDC guidance further outlines the appropriate use of the new diagnosis code. If the CDC makes additional recommendations in the future, please adhere to updated guidance.